Earnings4553TOWA PHARMACEUTICAL CO.,LTD.
TOWA Pharmaceutical Reports Q1 Revenue of 71.4 billion, Up 10%
TOKYO, Aug 06 (Pulse News Wire) – Towa Pharmaceutical Co., Ltd. (4553.T) reported consolidated results for Q1 FY2027 (ending March 2027).
Revenue was ¥71.4 billion (+9.6% YoY). operating profit was ¥6,519 million (+25.2%). net profit attributable to shareholders was ¥5,531 million (+120.1%).
Total assets stood at ¥480 billion with an equity ratio of 38.0%. The company declared an annual dividend of ¥45 per share. The full-year forecast for the current fiscal year is revenue of ¥300 billion (+11.1%).
Financial results — FY2027/3 (consolidated)
| Metric | Current | YoY |
|---|---|---|
| Revenue | ¥71,380M | +9.6% |
| Operating profit | ¥6,519M | +25.2% |
| Net profit | ¥5,531M | +120.1% |
Next period forecast
Revenue
¥304,000M
+11.1%Op. profit
¥32,000M
+38.5%Net profit
¥21,500M
+309.5%Figures in millions of yen
End of article